Task: Answer the multiple choice question.
Question: Which drug exhibits a 18.336% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) Cc1c(C(=O)N2CCCC2)c(S(=O)(=O)N2CCN(c3ccccc3F)CC2)c(C)n1C
b.) CCc1nnc(NC(=O)[C@@H](NC(=O)c2ccc(OC)cc2)C(C)C)s1
Answer: b. CCc1nnc(NC(=O)[C@@H](NC(=O)c2ccc(OC)cc2)C(C)C)s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCc1nnc(NC(=O)[C@@H](NC(=O)c2ccc(OC)cc2)C(C)C)s1
CCc1nnc(NC(=O)[C@@H](NC(=O)c2ccc(OC)cc2)C(C)C)s1
N-[(2S)-1-[(5-ethyl-1,3,4-thiadiazol-2-yl)amino]-3-methyl-1-oxobutan-2-yl]-4-methoxybenzamide